Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
5.835
Zitationen
27
Autoren
2015
Jahr
Abstract
Among patients with previously treated advanced renal-cell carcinoma, overall survival was longer and fewer grade 3 or 4 adverse events occurred with nivolumab than with everolimus. (Funded by Bristol-Myers Squibb; CheckMate 025 ClinicalTrials.gov number, NCT01668784.).
Ähnliche Arbeiten
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
2017 · 15.273 Zit.
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
2013 · 6.558 Zit.
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 · 5.730 Zit.
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
2007 · 4.770 Zit.
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
2018 · 4.535 Zit.
Autoren
- Robert J. Motzer
- Bernard Escudier
- Ray McDermott
- Saby George
- Hans J. Hammers
- Sandhya Srinivas
- Scott S. Tykodi
- Jeffrey A. Sosman
- Giuseppe Procopio
- Elizabeth R. Plimack
- Daniel Castellano
- Toni K. Choueiri
- Howard Gurney
- Frede Donskov
- Petri Bono
- John Wagstaff
- Thomas Gauler
- Takeshi Ueda
- Yoshihiko Tomita
- Fabio A.B. Schutz
- Christian Kollmannsberger
- James Larkin
- Alain Ravaud
- Jason S. Simon
- Li-An Xu
- Ian M. Waxman
- Padmanee Sharma
Institutionen
- Johns Hopkins University(US)
- Memorial Sloan Kettering Cancer Center(US)
- Institut Gustave Roussy(FR)
- Hadassah Medical Center(IL)
- Roswell Park Comprehensive Cancer Center(US)
- Sidney Kimmel Comprehensive Cancer Center(US)
- Cancer Prevention Institute of California(US)
- Stanford Cancer Institute
- University of Washington(US)
- Fred Hutch Cancer Center(US)
- Vanderbilt University Medical Center(US)
- Fondazione IRCCS Istituto Nazionale dei Tumori(IT)
- Mylan (Switzerland)(CH)
- Fox Chase Cancer Center(US)
- Hospital Universitario 12 De Octubre(ES)
- Brigham and Women's Hospital(US)
- Dana-Farber Brigham Cancer Center(US)
- Harvard University(US)
- Dana-Farber Cancer Institute(US)
- Macquarie University(AU)
- Westmead Hospital(AU)
- Aarhus University Hospital(DK)
- Helsinki University Hospital(FI)
- University of Helsinki(FI)
- Cancer Institute (WIA)(IN)
- Swansea University(GB)
- University of Duisburg-Essen(DE)
- Chiba Cancer Center(JP)
- Niigata University of Management(JP)
- Beneficência Portuguesa de São Paulo(BR)
- BC Cancer Agency(CA)
- Royal Marsden Hospital(GB)
- Hôpital Saint-André(FR)
- Bristol-Myers Squibb (Belgium)(BE)
- The University of Texas MD Anderson Cancer Center(US)